Fundraising Fox
/Companies
Sign in

ACX

YC S24

New York City, US · Founded 2024 · 4 employees · 1 known investors

Find your way into ACX

11,014 people in our graph can introduce you to the ACX team.

Sign up to see every warm intro you have to ACX

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the ACX team. We find them
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

ACX develops bioengineered solutions for pest control in agriculture, replacing synthetic chemicals with precision biocides. The company serves crop producers and aims to enhance food security while reducing chemical dependence and promoting biodiversity.

Also known as AcX Therapeutics, Inc. · AcX Therapeutics · AcX Therapeutics, AcX

AgTechBiotechHealthtechSynthetic BiologyHealthcareAgricultureDrug discoveryUnited States of AmericaAmerica / Canada

Founders & leadership· Y Combinator alumni (S24)

ACX was founded in 2024 by Emmanouela Petsolari and Melina Petsolari.

EPEmmanouela Petsolari
Emmanouela PetsolariCo-Founder and CEOEmmanouela Petsolari holds a PhD in Biochemistry and Biophysics from the University of Cambridge and has conducted research across immunology, cancer, vaccine development, and drug discovery at institutions including Barts Cancer Institute, Cambridge University, King's College London, Institute Curie, and Imperial College London. She is Co-Founder and CEO of ACX.
MPMelina Petsolari
Melina PetsolariCo-Founder and CTOMelina Petsolari holds a PhD in Computer Science from King's College London and previously conducted research in digital health, robotics, human-computer interaction, and natural language processing at institutions including Cambridge University, King's College London, the NHS, and the Francis Crick Institute.

Investors · 1

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

Related companies · 9

TradingViewTradingView is a charting platform and social network used by over 100 million traders and investors worldwide to analyze and trade across global financial markets. The platform provides tools for technical analysis, market data, and community collaboration for retail and institutional traders.
Engage BioEngageBio develops DNA-based medicines using proprietary non-viral delivery technology to achieve extended therapeutic expression from a single dose with low manufacturing complexity.
RobinhoodRobinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets. The platform serves retail investors with low barriers to entry, offering portfolio management services and market insights.
MolagriMolagri develops biopesticides that target harmful insects through specific molecular mechanisms while protecting beneficial insects and the environment, and incorporates resistance modeling to maintain product efficacy over time.
Acurx PharmaceuticalsAcurx Pharmaceuticals is a clinical-stage biopharmaceutical company developing a new class of antibiotics targeting bacterial infections classified as priority pathogens by the WHO, CDC, and FDA. It is a publicly held company focused on antibiotic drug development.
Ohmic BiosciencesOhmic Biosciences develops engineered proteins and synthetic biology solutions to address diseases in crops. The company creates durable treatments applicable across different agricultural products.
ActXActX provides genomic clinical decision support integrated directly into electronic health record software, automatically checking prescriptions for efficacy, adverse reactions, and dosing based on a patient's genetics. It serves health systems and providers with real-time pharmacogenomics and precision medicine, and also offers individuals medical analysis of their DNA data.
Living CarbonLiving Carbon develops precision-bred tree varieties and reforestation techniques to convert marginal land into carbon-sequestering ecosystems. The company targets climate mitigation through enhanced photosynthesis and biodiversity restoration.
SynviviaSynvivia engineers molecules designed to reprogram cells. The company operates in the biotech sector.

Companies working in the same space as ACX.

Legal entities · 1

corporate structure
AcX Therapeutics, Inc.

In the news

🧬🦠 ACX – Next-generation biocides for sustainable agriculture at scaleycombinator.com · Jul 2024

Frequently asked questions

What does ACX do?
ACX develops bioengineered solutions for pest control in agriculture, replacing synthetic chemicals with precision biocides. The company serves crop producers and aims to enhance food security while reducing chemical dependence and promoting biodiversity.
Who founded ACX?
ACX was founded by Emmanouela Petsolari, Melina Petsolari in 2024.
Who are ACX's investors?
ACX's investors include Y Combinator.
Where is ACX headquartered?
ACX is headquartered in New York City, US.